Pomegranate’s reputation runs on one word: mitophagy. Search for pomegranate and antioxidants and the results fill up with headlines about mitochondrial health, muscle strength, and slowing cellular aging. The compound behind almost all of it is urolithin A, and the studies behind those headlines are real, published, peer-reviewed research.
Here is what those headlines leave out: pomegranate does not contain urolithin A. Nobody’s pomegranate juice, powder, or supplement does. The fruit contains ellagitannins and ellagic acid, compounds your gut bacteria have to convert into urolithin A before any of that research applies to you. Whether that conversion happens at all depends on which bacteria happen to live in your colon, and a meaningful share of people simply don’t have the ones required.
The Trials Everyone Cites Didn’t Use Pomegranate
Start with the actual evidence. A randomized, placebo-controlled trial published in Nature Aging in 2025 found that daily urolithin A supplementation improved immune cell function in healthy middle-aged adults over four weeks, shifting T-cells toward a more youthful, energy-efficient profile. A separate trial found roughly 12 percent improvements in muscle strength over four months. Both used direct oral urolithin A, dosed at 500 to 1,000 milligrams per day.
That dose is not something you get from eating fruit. A published comparison found that a 500 milligram direct dose of urolithin A produced blood levels roughly six times higher than drinking eight ounces of 100 percent pomegranate juice. The gap exists because juice never delivers urolithin A in the first place. It delivers the raw material, and your body’s ability to finish the job is the part nobody puts on the label.
Meet the Bacteria Actually Doing the Work
Ellagitannins break down into ellagic acid in the small intestine. From there, ellagic acid travels to the colon, where specific bacteria, most notably a genus called Gordonibacter, metabolize it step by step into urolithins. Gordonibacter urolithinfaciens was one of the first bacterial species identified as capable of this conversion, isolated directly from human feces and confirmed in laboratory studies to turn ellagic acid into the bioactive urolithin compounds researchers had been measuring in blood and urine for years without knowing exactly where they came from.
Bifidobacterium species appear to play a supporting role in some individuals as well. But the presence, absence, and relative abundance of these specific bacterial strains is not something diet alone reliably controls, and it is not something a food label can account for.
Metabotypes: Why the Same Pomegranate Powder Does Different Things to Different People
Researchers classify people into three groups based on what their gut bacteria actually produce from ellagitannins, called urolithin metabotypes.
Metabotype A converts ellagic acid all the way to urolithin A, the compound behind the mitophagy and immune research. The Metabotype B produces urolithin A along with isourolithin A and urolithin B, a broader but less-studied mix. Metabotype 0 produces none of the three. Not less. None. A person with metabotype 0 can eat pomegranate every day for a year and never generate a measurable amount of urolithin A, because the specific bacteria required to make that conversion are simply not present in their gut.
How common is metabotype 0? The honest answer is that the studies disagree, and the disagreement itself is informative. Research on Spanish adults following a Mediterranean diet found roughly 10 percent fell into metabotype 0. A study of Chinese subjects found about 14 percent. Estimates for general Western populations, including the United States, have ranged as high as 50 to 60 percent non-producers in some analyses. Diet, baseline gut microbiome diversity, and regional differences in bacterial exposure all appear to move that number substantially. There is no single figure that applies to everyone, and any article that hands you one specific percentage as a universal fact is oversimplifying research that its own authors describe as highly variable.
What is not in dispute: a large, clinically meaningful portion of the population does not convert pomegranate’s ellagitannins into urolithin A at all, regardless of how much pomegranate they eat.
You Can’t Currently Find Out Which One You Are
Determining your own metabotype requires collecting a 24-hour urine sample and running it through mass spectrometry to identify and quantify specific urolithin compounds. This is a research-lab procedure, not a consumer test. It is not available at a pharmacy, not offered by any mainstream at-home testing kit, and not something your doctor can order as a standard panel. Short of enrolling in a clinical study, there is currently no practical way to know in advance whether pomegranate will do anything measurable for you through this specific pathway.
That uncertainty is precisely why direct urolithin A supplementation exists as a separate product category from pomegranate extracts. A study published in the European Journal of Clinical Nutrition found that direct urolithin A supplementation produced consistent blood levels across a study population regardless of individual gut microbiome differences, something dietary ellagitannin sources cannot promise anyone. The clinical trials behind the mitophagy and immune headlines relied on that consistency. Pomegranate consumption cannot offer it.
What This Actually Means If You’re Buying Pomegranate for This Reason
None of this makes pomegranate juice powder pointless, and it would be dishonest to claim otherwise. Ellagic acid itself carries independent antioxidant activity before any bacterial conversion takes place, and someone with metabotype 0 still absorbs and benefits from that. Pomegranate also contains anthocyanins, vitamin C, and other polyphenols entirely separate from the ellagitannin pathway. A juice powder still delivers real, measurable nutritional value regardless of which metabotype you happen to be.
What pomegranate cannot promise, no matter how the label frames it, is the specific mitophagy and mitochondrial benefit demonstrated in the urolithin A clinical trials. That evidence exists for a different, downstream compound your gut bacteria may or may not produce from what you actually ate. The marketing language treats “pomegranate” and “urolithin A” as close enough to be interchangeable. The biochemistry does not agree.
If mitochondrial and mitophagy research is specifically why you’re buying a pomegranate product, know what you’re actually purchasing: a source of raw material with no guarantee your body can finish the conversion, rather than the compound the studies were built on.
Honest Recommendation
Buy pomegranate powder for real, concentrated polyphenols, genuine antioxidant content, and flavor. Don’t buy it specifically chasing the mitophagy and immune-aging research, since that evidence was built on a downstream compound your gut may never produce from it. If the urolithin A research is what actually drew you to pomegranate in the first place, understand that the fruit is a starting material with an uncertain finish line, not the compound itself.
For our brand-by-brand breakdown of what’s actually in the jar, including why almost every “pomegranate powder” on the market is juice powder rather than whole fruit, see our organic pomegranate powder roundup.
Sources
- Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial, Nature Aging, 2025
- Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults, PubMed
- Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability, PMC
- Gordonibacter urolithinfaciens sp. nov., a urolithin-producing bacterium isolated from the human gut, PubMed
- Urolithin Metabotypes Can Determine the Modulation of Gut Microbiota in Healthy Individuals, PMC
- Clustering according to urolithin metabotype explains interindividual variability in cardiovascular risk biomarker improvement after pomegranate consumption, PubMed
This article is for informational purposes and is not medical advice.
